Pharmora provides assured, global medical review services for the clinical development, marketing and safety surveillance of medical products, from the first clinical trials to ongoing commercialisation. Our highly capable team of medics and scientists are available to provide flexible and dedicated services, at your convenience.

Large Pharma

If you are part of a medium or large global pharmaceutical company,  Pharmora can support your clinical development, patient safety, and medical affairs needs. Click here to learn more.

Biotech / Investor

If you’re part of a small organisation, such as a biotech company, click here to discover how we can support you. We also assist investors with due diligence on small companies/ assets, whether in development or already on the market.

Regulatory Agency

If you work for a regulatory agency and require additional support in assessing marketing authorisation applications, click here to learn more about how we can assist you.

What can Pharmora do?

 

Pharmora is a preferred strategic partner for the following services:

Clinical Development

Pharmora can provide medical and scientific expertise to support your clinical development projects at all phases and through regulatory submission to approval

Patient Safety

Pharmora is built on a foundation of safety expertise throughout the product life cycle

Medical & Regulatory Writing

Pharmora can work seamlessly with your team to evaluate the data and ensure the documents accurately convey your key messages

Training and more

Pharmora runs training courses on key skills and can provide bespoke training packages depending on your needs

Where are you in the

Product Life

Cycle?

Pre-clinical

Early clinical development

Phase II-III clinical
development

NDA / MAA submission

Life cycle
management

Our latest thinking

Conversations with Industry Leaders: Dr Sue Lim 1 April 2025

Conversations with Industry Leaders: Dr Sue Lim 1 April 2025

By Dr Stephanie-Jayne Jones

On 1st April I caught up with Dr Sue Lim in the latest in my series of “Conversations with Leaders in our Industry”. Dr Lim is an experienced former FDA director and licensed physician with around 2 decades of global drug development experience.

read more
Conversation with Industry Leaders: Professor Alan Boyd 11 April 2025

Conversation with Industry Leaders: Professor Alan Boyd 11 April 2025

Continuing conversations with industry leaders, CMO Dr Jones interviews Professor Alan Boyd, ex President of the FPM. Some of you will know him as the former President of the Faculty of Pharmaceutical Medicine, some will know him as the entrepreneur who created @Boyds and others will know him as an engaging and expert mentor, dedicated to training and empowering the next generation of people working in the pharmaceutical industry.

read more